These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28838159)

  • 1. A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply Market.
    Lewis I; Ottosen A; Rubin J; Blanc DC; Zipursky S; Wootton E
    J Infect Dis; 2017 Jul; 216(suppl_1):S33-S39. PubMed ID: 28838159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communications, Immunization, and Polio Vaccines: Lessons From a Global Perspective on Generating Political Will, Informing Decision-Making and Planning, and Engaging Local Support.
    Menning L; Garg G; Pokharel D; Thrush E; Farrell M; Kodio FK; Veira CL; Wanyoike S; Malik S; Patel M; Rosenbauer O
    J Infect Dis; 2017 Jul; 216(suppl_1):S24-S32. PubMed ID: 28838189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame.
    Zipursky S; Patel M; Farrell M; Gonzalez AR; Kachra T; Folly Y; Kurji F; Veira CL; Wootton E; Hampton LM
    J Infect Dis; 2017 Jul; 216(suppl_1):S15-S23. PubMed ID: 28838203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.
    Ramirez Gonzalez A; Farrell M; Menning L; Garon J; Everts H; Hampton LM; Dolan SB; Shendale S; Wanyoike S; Veira CL; Châtellier GMD; Kurji F; Rubin J; Boualam L; Chang Blanc D; Patel M
    J Infect Dis; 2017 Jul; 216(suppl_1):S183-S192. PubMed ID: 28838179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
    Gamage D; Ginige S; Palihawadana P
    WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.
    Gurung S; Harris JB; Eltayeb AO; Hampton LM; Diorditsa S; Avagyan T; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S101-S108. PubMed ID: 28838170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
    Thacker N; Thacker D; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptional Financial Support for Introduction of Inactivated Polio Vaccine in Middle-Income Countries.
    Blankenhorn AL; Cernuschi T; Zaffran MJ
    J Infect Dis; 2017 Jul; 216(suppl_1):S52-S56. PubMed ID: 28838169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
    Patel M; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S1-S8. PubMed ID: 28838196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polio Endgame: Lessons Learned From the Immunization Systems Management Group.
    Zipursky S; Vandelaer J; Brooks A; Dietz V; Kachra T; Farrell M; Ottosen A; Sever JL; Zaffran MJ
    J Infect Dis; 2017 Jul; 216(suppl_1):S9-S14. PubMed ID: 28838174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
    Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.
    Fahmy K; Hampton LM; Langar H; Patel M; Mir T; Soloman C; Hasman A; Yusuf N; Teleb N
    J Infect Dis; 2017 Jul; 216(suppl_1):S86-S93. PubMed ID: 28838199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remarks on the possibility of the introduction of fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule].
    Arbo A; Falleiros-Arlant LH; López EL; Brea Del Castillo J; Martínez de Cuellar C; Moreno G; Rolón R; Cerda J; Eguiazú S;
    Rev Chilena Infectol; 2018 Aug; 35(4):395-402. PubMed ID: 30534926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.
    Tevi-Benissan C; Okeibunor J; du Châtellier GM; Assefa A; Biey JN; Cheikh D; Eshetu M; Anya BP; Dao H; Nasir Y; Akanmori BD; Mihigo R
    J Infect Dis; 2017 Jul; 216(suppl_1):S66-S75. PubMed ID: 28838178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria.
    Scotney S; Snidal S; Saidu Y; Ojumu A; Ngatia A; Bagana M; Mutuku F; Sobngwi J; Efe-Aluta O; Roper J; LeTallec Y; Kang'ethe A
    J Infect Dis; 2017 Jul; 216(suppl_1):S130-S136. PubMed ID: 28838156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.
    Wkly Epidemiol Rec; 2003 Jul; 78(28):241-50. PubMed ID: 15571166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polio endgame: rationale behind the change in immunisation.
    Garon J; Patel M
    Arch Dis Child; 2017 Apr; 102(4):362-365. PubMed ID: 28096107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.